{"title":"美国、欧洲、日本和中国生物技术发明专利的比较分析","authors":"Weiwei Han","doi":"10.2139/ssrn.2225845","DOIUrl":null,"url":null,"abstract":"Biotechnology has been developing at a dramatic pace. The success story of modern biotechnology industry is closely linked with the evolution of modern patent law and patents are pillars of biotechnology industry. The context for patenting DNA sequences has changed markedly since the 1990s. Recent decisions regarding biotechnology inventions have aroused rethinking of the important issues in this unique field globally. The thesis will conduct a comparative analysis of patenting biotechnology inventions in the U.S., Europe, Japan and China. Doctrines and practice regarding patent eligibility, utility, novelty, inventive step and enablement will be introduced and discussed in connection with typical cases and recent decisions. Unique requirements, including requirement for patent disclosure of the source of genetic resources in China, will be highlighted.","PeriodicalId":208710,"journal":{"name":"LSN: Patent Law/Intellectual Property (Topic)","volume":"30 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Analysis of Patenting Biotechnology Inventions in the U.S., Europe, Japan and China\",\"authors\":\"Weiwei Han\",\"doi\":\"10.2139/ssrn.2225845\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Biotechnology has been developing at a dramatic pace. The success story of modern biotechnology industry is closely linked with the evolution of modern patent law and patents are pillars of biotechnology industry. The context for patenting DNA sequences has changed markedly since the 1990s. Recent decisions regarding biotechnology inventions have aroused rethinking of the important issues in this unique field globally. The thesis will conduct a comparative analysis of patenting biotechnology inventions in the U.S., Europe, Japan and China. Doctrines and practice regarding patent eligibility, utility, novelty, inventive step and enablement will be introduced and discussed in connection with typical cases and recent decisions. Unique requirements, including requirement for patent disclosure of the source of genetic resources in China, will be highlighted.\",\"PeriodicalId\":208710,\"journal\":{\"name\":\"LSN: Patent Law/Intellectual Property (Topic)\",\"volume\":\"30 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"LSN: Patent Law/Intellectual Property (Topic)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2139/ssrn.2225845\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"LSN: Patent Law/Intellectual Property (Topic)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/ssrn.2225845","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparative Analysis of Patenting Biotechnology Inventions in the U.S., Europe, Japan and China
Biotechnology has been developing at a dramatic pace. The success story of modern biotechnology industry is closely linked with the evolution of modern patent law and patents are pillars of biotechnology industry. The context for patenting DNA sequences has changed markedly since the 1990s. Recent decisions regarding biotechnology inventions have aroused rethinking of the important issues in this unique field globally. The thesis will conduct a comparative analysis of patenting biotechnology inventions in the U.S., Europe, Japan and China. Doctrines and practice regarding patent eligibility, utility, novelty, inventive step and enablement will be introduced and discussed in connection with typical cases and recent decisions. Unique requirements, including requirement for patent disclosure of the source of genetic resources in China, will be highlighted.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
